These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17566869)

  • 1. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.
    Chen LC; Ashcroft DM; Elliott RA
    Pharm World Sci; 2007 Dec; 29(6):661-70. PubMed ID: 17566869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey.
    Späth HM; Charavel M; Morelle M; Carrere MO
    Pharm World Sci; 2003 Dec; 25(6):269-75. PubMed ID: 14689815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators.
    Roseboom KJ; van Dongen JM; Tompa E; van Tulder MW; Bosmans JE
    BMC Health Serv Res; 2017 Jan; 17(1):89. PubMed ID: 28126005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
    Hanna LA; Hughes C
    Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians.
    Billaux M; Borget I; Prognon P; Pineau J; Martelli N
    Aust Health Rev; 2016 Jun; 40(3):257-261. PubMed ID: 26342894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How organizational context affects bioethical decision-making: pharmacists' management of gatekeeping processes in retail and hospital settings.
    Chiarello E
    Soc Sci Med; 2013 Dec; 98():319-29. PubMed ID: 23337832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdisciplinary medication decision making by pharmacists in pediatric hospital settings: An ethnographic study.
    Rosenfeld E; Kinney S; Weiner C; Newall F; Williams A; Cranswick N; Wong I; Borrott N; Manias E
    Res Social Adm Pharm; 2018 Mar; 14(3):269-278. PubMed ID: 28377092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What role do pharmacists play in mediating antibiotic use in hospitals? A qualitative study.
    Broom A; Broom J; Kirby E; Plage S; Adams J
    BMJ Open; 2015 Nov; 5(11):e008326. PubMed ID: 26534731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges to clinical pharmacy practice in Nigerian hospitals: a qualitative exploration of stakeholders' views.
    Auta A; Strickland-Hodge B; Maz J
    J Eval Clin Pract; 2016 Oct; 22(5):699-706. PubMed ID: 26969559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived facilitators to change in hospital pharmacy practice in England.
    Auta A; Maz J; Strickland-Hodge B
    Int J Clin Pharm; 2015 Dec; 37(6):1068-75. PubMed ID: 26195124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring attitudes and opinions of pharmacists toward delivering prescribing error feedback: A qualitative case study using focus group interviews.
    Lloyd M; Watmough SD; O'Brien SV; Furlong N; Hardy K
    Res Social Adm Pharm; 2016; 12(3):461-74. PubMed ID: 26482469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
    Lucas B; Blenkinsopp A
    Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative study on pharmacists' perception on integrating pharmacists into private general practitioner's clinics in Malaysia.
    Saw PS; Nissen L; Freeman C; Wong PS; Mak V
    Pharm Pract (Granada); 2017; 15(3):971. PubMed ID: 28943979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-the-counter prescribing and pharmacists' adoption of new medicines: diffusion of innovations.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2013; 9(3):251-62. PubMed ID: 22835710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.